Almond Consumption and Risk Factors for Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials

被引:49
作者
Lee-Bravatti, Michelle A. [1 ]
Wang, Jifan [1 ]
Avendano, Esther E. [2 ]
King, Ligaya [1 ]
Johnson, Elizabeth J. [3 ]
Raman, Gowri [2 ]
机构
[1] Tufts Univ, Friedman Sch Nutr & Policy, Boston, MA 02111 USA
[2] Tufts Med Ctr, Tufts Clin Evidence Synth Ctr, Boston, MA 02111 USA
[3] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA
关键词
systematic review; meta-analysis; blood lipids; risk factors; metabolic syndrome; hypertension; hyperglycemia; hypercholesterolemia; obesity; CORONARY-HEART-DISEASE; NUT CONSUMPTION; DIETARY; WEIGHT; LIPIDS; LIPOPROTEINS; ADULTS; DEATH; WOMEN;
D O I
10.1093/advances/nmz043
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Evidence suggests that eating nuts may reduce the risk of cardiovascular disease (CVD). We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating almond consumption and risk factors for CVD. MEDLINE, Cochrane Central, Commonwealth Agricultural Bureau, and previous systematic reviews were searched from 1990 through June 2017 for RCTs of >= 3 wk duration that evaluated almond compared with no almond consumption in adults who were either healthy or at risk for CVD. The most appropriate stratum was selected with an almond dose closer to 42.5 g, with a control most closely matched for macronutrient composition, energy intake, and similar intervention duration. The outcomes included risk factors for CVD. Random-effects model meta-analyses and subgroup meta-analyses were performed. Fifteen eligible trials analyzed a total of 534 subjects. Almond intervention significantly decreased total cholesterol (summary net change: -10.69 mg/dL; 95% CI: -16.75, -4.63 mg/dL), LDL cholesterol (summary net change: -5.83 mg/dL; 95% CI: -9.91, -1.75 mg/dL); body weight (summary net change: -1.39 kg; 95% CI: -2.49, -0.30 kg), HDL cholesterol (summary net change: -1.26 mg/dL; 95% CI: -2.47, -0.05 mg/dL), and apolipoprotein B (apoB) (summary net change: -6.67 mg/dL; 95% CI: -12.63, -0.72 mg/dL). Triglycerides, systolic blood pressure, apolipoprotein A1, high-sensitivity C-reactive protein, and lipoprotein (a) showed no difference between almond and control in the main and subgroup analyses. Fasting blood glucose, diastolic blood pressure, and body mass index significantly decreased with almond consumption of >42.5 g compared with <= 42.5 g. Almond consumption may reduce the risk of CVD by improving blood lipids and by decreasing body weight and apoB. Substantial heterogeneity in eligible studies regarding almond interventions and dosages precludes firmer conclusions.
引用
收藏
页码:1076 / 1088
页数:13
相关论文
共 39 条
  • [21] Nuts and coronary heart disease:: an epidemiological perspective
    Kelly, John H., Jr.
    Sabate, Joan
    [J]. BRITISH JOURNAL OF NUTRITION, 2006, 96 (01) : S61 - S67
  • [22] KrisEtherton PM, 1997, AM J CLIN NUTR, V65, P1590
  • [23] Cardioprotective effects of chocolate and almond consumption in healthy women
    Kurlandsky, Sara B.
    Stote, Kim S.
    [J]. NUTRITION RESEARCH, 2006, 26 (10) : 509 - 516
  • [24] Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus
    Li, Sing-Chung
    Liu, Yen-Hua
    Liu, Jen-Fang
    Chang, Wen-Hsin
    Chen, Chiao-Ming
    Chen, C-Y. Oliver
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (04): : 474 - 479
  • [25] Application of Systematic Review Methodology to the Field of Nutrition
    Lichtenstein, Alice H.
    Yetley, Elizabeth A.
    Lau, Joseph
    [J]. JOURNAL OF NUTRITION, 2008, 138 (12) : 2297 - 2306
  • [26] Linton M.F., 2000, Endotext
  • [27] Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes
    Lovejoy, JC
    Most, MM
    Lefevre, M
    Greenway, FL
    Rood, JC
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 76 (05) : 1000 - 1006
  • [28] Moher D, 2010, INT J SURG, V8, P658, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097, 10.1016/j.ijsu.2010.07.299, 10.1186/2046-4053-4-1, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.i4086, 10.1136/bmj.b2700]
  • [29] The effects of almond consumption on fasting blood lipid levels: a systematic review and meta-analysis of randomised controlled trials
    Musa-Veloso, Kathy
    Paulionis, Lina
    Poon, Theresa
    Lee, Han Youl
    [J]. JOURNAL OF NUTRITIONAL SCIENCE, 2016, 5
  • [30] Statins and almonds to lower lipoproteins (the STALL Study)
    Ruisinger, Janette F.
    Gibson, Cheryl A.
    Backes, James M.
    Smith, Bryan K.
    Sullivan, Debra K.
    Moriarty, Patrick M.
    Kris-Etherton, Penny
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2015, 9 (01) : 58 - 64